 VANCOUVER and MINNEAPOLIS, Sept. 28, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- Neovasc Inc. Neovasc or the Company NASDAQ, TSX: NVCN today announced the publication of an article entitled, Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study the REDUCER-I study in the September 2021 issue of the journal EuroIntervention. 